The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of ActionPhilippe Gallay, Robert T. Foster, Daren Ure et al.|PLoS ONE|2015Cited by 37
P0890 : Novel cyclophilin inhibitor CPI-431-32 shows broad spectrum antiviral activity by blocking replication of HCV, HBV and HIV-1 virusesPhilippe Gallay, Cosme Ordonez, Udayan Chatterji et al.|Journal of Hepatology|2015Cited by 4